Your browser doesn't support javascript.
loading
A retinoic acid receptor alpha antagonist counteracts retinoid teratogenicity in vitro and reduced incidence and/or severity of malformations in vivo.
Eckhardt, K; Schmitt, G.
Affiliation
  • Eckhardt K; Pharma Division, Preclinical Research, F. Hoffmann-La Roche Ltd., Basel, Switzerland.
Toxicol Lett ; 70(3): 299-308, 1994 Feb 15.
Article in En | MEDLINE | ID: mdl-8284797
Search on Google
Collection: 01-internacional Database: MEDLINE Main subject: Retinoids / Tetrahydronaphthalenes / Abnormalities, Drug-Induced / Benzoates / Chromans / Receptors, Retinoic Acid / Extremities Type of study: Incidence_studies / Risk_factors_studies Limits: Animals / Pregnancy Language: En Journal: Toxicol Lett Year: 1994 Document type: Article Affiliation country: Suiza Country of publication: Países Bajos
Search on Google
Collection: 01-internacional Database: MEDLINE Main subject: Retinoids / Tetrahydronaphthalenes / Abnormalities, Drug-Induced / Benzoates / Chromans / Receptors, Retinoic Acid / Extremities Type of study: Incidence_studies / Risk_factors_studies Limits: Animals / Pregnancy Language: En Journal: Toxicol Lett Year: 1994 Document type: Article Affiliation country: Suiza Country of publication: Países Bajos